section name header

Evidence summaries

Topical Glyceryl Trinitrate for Rotator Cuff Disease

Topical glyceryl trinitrate may slightly improve pain among patients with acute symptoms of rotator cuff disease. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 3 RCTs with a total of 93 subjects with rotator cuff disease. One placebo-controlled trial (20 participants) tested 5 mg glyceryl trinitrate patches, used daily for 3 days, among participants with 'acute supraspinatus tendinitis' of less than 7 days duration. Treatment resulted in reduced pain intensity (adjusted MD -3.50, 95% CI -3.96 to -3.04). Function was not measured. One trial (53 participants) compared one quarter of a 5 mg glyceryl trinitrate patch used daily for up to 24 weeks combined with rehabilitation to placebo patches and rehabilitation among participants with 'supraspinatus tendinopathy' for longer than 6 months. A third trial (48 participants) tested 5 mg glyceryl trinitrate patches, used daily for 3 days, compared to corticosteroid injection among participants with 'rotator cuff tendinitis' of less than 6-weeks duration. An appropriate measure of pain was not reported and function was not measured. Fifteen out of 24 participants in the glyceryl trinitrate treatment reported headache (RR 0.11, 95% CI 0.01 to 1.96).

Comment: The quality of evidence is downgraded by imprecise results (few patients) and by inconsistency (heterogeneity in studied interventions and outcomes).

References

  • Cumpston M, Johnston RV, Wengier L, Buchbinder R. Topical glyceryl trinitrate for rotator cuff disease. Cochrane Database Syst Rev 2009 Jul 8;(3):CD006355. [PubMed]

Primary/Secondary Keywords